{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:47:56Z","timestamp":1789015676827,"version":"build-2803163510"},"reference-count":7,"publisher":"SAGE Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2024,5,14]]},"abstract":"<jats:p>As the biological, biomarker-driven framework of Alzheimer\u2019s disease (AD) becomes formalized through revised, consensus clinical criteria, clinicians will confront more and more patients in the earliest, asymptomatic stages of disease. The language and diction used by practitioners to characterize these early patients, whether they are diagnosed with AD, and how their condition is documented in medical and legal records have important implications for both their care and their medical-legal status outside of the health system. Investigation is needed urgently to better understand clinicians\u2019 views and practices regarding early AD, as we adapt to new disease definitions in this unprecedented era of care.<\/jats:p>","DOI":"10.3233\/jad-240195","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T11:39:25Z","timestamp":1714477165000},"page":"489-492","source":"Crossref","is-referenced-by-count":4,"title":["Language and Meaning: Asymptomatic Alzheimer\u2019s Disease in the Clinic and Society"],"prefix":"10.1177","volume":"99","author":[{"given":"Seth A.","family":"Gale","sequence":"first","affiliation":[{"name":"Department of Neurology, Center for Brain\/Mind Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-240195_ref1","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jalz.2018.07.220","article-title":"Appropriate use criteria for lumbar puncture and cerebrospinal fluid testing in the diagnosis of Alzheimer\u2019s disease","volume":"14","author":"Shaw","year":"2018","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-240195_ref2","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.2967\/jnumed.113.127068","article-title":"Update on appropriate use criteria for amyloid PET imaging: Dementia experts, mild cognitive impairment, and education","volume":"54","author":"Johnson","year":"2013","journal-title":"J Nucl Med"},{"key":"10.3233\/JAD-240195_ref3","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s43657-022-00068-9","article-title":"International Nuclear Medicine Consensus on the clinical use of amyloid positron emission tomography in Alzheimer\u2019s disease","volume":"3","author":"Tian","year":"2023","journal-title":"Phenomics"},{"key":"10.3233\/JAD-240195_ref5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1093\/jmp\/jhad009","article-title":"Preclinical disease or risk factor? Alzheimer\u2019s disease as a case study of changing conceptualizations of disease","volume":"48","author":"Schermer","year":"2023","journal-title":"J Med Philos"},{"key":"10.3233\/JAD-240195_ref6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1177\/1073110518782955","article-title":"The proactive patient: Long-term care insurance discrimination risks of Alzheimer\u2019s disease biomarkers","volume":"46","author":"Arias","year":"2018","journal-title":"J Law Med Ethics"},{"key":"10.3233\/JAD-240195_ref7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1212\/WNL.0000000000000153","article-title":"Confidentiality in preclinical Alzheimer disease studies: When research and medical records meet","volume":"82","author":"Arias","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-240195_ref8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-230067","article-title":"Creating an unprotected class: Addressing legal risks in the era of biologically-defined Alzheimer\u2019s disease","volume":"98","author":"Vaishnav","year":"2024","journal-title":"J Alzheimers Dis"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-240195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:37Z","timestamp":1777370917000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-240195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,14]]},"references-count":7,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.3233\/jad-240195","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,14]]}}}